Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC vs FFP in Goal-directed Bleeding Management in Cardiac Surgery
NCT06144125Phase 4Recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of prothrombin complex concentrate, human in Cardiac valve disease (VHD) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Treatment Time at 1 month. Started Mar 2026; status: recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on NCT06144125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144125.